Market Overview:
The global proteinase K market size is projected to exhibit a growth rate (CAGR) of 6.39% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Growth Rate 2024-2032 |
6.39% |
Proteinase K is a serine alkaline protease that is widely utilized in protein digest. It is also used in molecular biology to remove contamination from nuclear acid preparations. Moreover, as it assists in the removal of endotoxins bound to cationic patients, such as ribonuclease A and lysozyme, determination of enzyme localization on membranes, and digestion of proteins from brain tissue samples, its demand is escalating around the world.
A considerable rise in the demand for nucleic acid purification, tissue digestion and improved cloning efficiency represents one of the primary factors strengthening the global market growth. The increasing prevalence of infectious diseases and the wide applicability of proteinase K in diagnosing these diseases is also fueling the growth of the market. Apart from this, as the incubation of DNA from the Hepatitis B virus (HBV) with proteinase K aids in efficient DNA isolation, its demand is rising across the globe. It also finds extensive application in the treatment of paraffin-embedded sections of tissues during antibody labeling and isolation of mitochondria from hepatic cells. Additionally, it is used during the polymerase chain reaction (PCR) purification for a wide range of in-vitro diagnostics (IVD) applications. Furthermore, the sudden outbreak of the coronavirus disease (COVID-19) is positively influencing the market growth as proteinase K is employed in the pre-treatment to detect the SARS-CoV-2 in samples collected without the need for RNA extraction.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global proteinase K market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapeutic area, type, form and end user.
Breakup by Therapeutic Area:
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune Diseases
- Neurology
- Others
Breakup by Type:
Breakup by Form:
Breakup by End User:
- Pharmaceutical Companies
- Academic and Research Centers
- Contract Research Organizations
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Enzymes Technologies Ltd., American Laboratories, Amicogen Inc., BBI Solutions, Biocatalysts Ltd., Codexis Inc., Dyadic International Inc., F. Hoffmann-La Roche Ltd. (Roche Ag), Merck KGaA, Qiagen N.V. and Thermo Fisher Scientific Inc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Therapeutic Area, Form, Type, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Advanced Enzymes Technologies Ltd., American Laboratories, Amicogen Inc., BBI Solutions, Biocatalysts Ltd., Codexis Inc., Dyadic International Inc., F. Hoffmann-La Roche Ltd. (Roche Ag), Merck KGaA, Qiagen N.V. and Thermo Fisher Scientific Inc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global proteinase k market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global proteinase k market?
- What are the key regional markets?
- What is the breakup of the market based on the therapeutic area?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the form?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global proteinase k market and who are the key players?
- What is the degree of competition in the industry?